<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT(DATE OF EARLIEST EVENT REPORTED): NOVEMBER 13, 1996
BARRINGER LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State of other jurisdiction of incorporation)
0-8241 84-0951626
(Commission (I.R.S. Employer
File Number) Identification No.)
15000 WEST SIXTH AVENUE, SUITE 300
GOLDEN, COLORADO 80401
(Address of principal executive offices, including zip code)
(303) 277-1687
(Registrant's telephone number, including area code)
<PAGE>
ITEM 5. OTHER EVENTS
Effective November 11, 1996, Stanley S. Binder resigned as a director of
Barringer Laboratories, Inc., subsequent to Barringer Technologies Inc.'s sale
of 250,000 shares or more of the issued and outstanding shares of Barringer
Laboratories, Inc. stock owned by Barringer Technologies Inc.
Effective November 11, 1996, John J. Harte resigned as a director and
Chairman of the Board of Barringer Laboratories, Inc., subsequent to Barringer
Technologies Inc.'s sale of 250,000 shares or more of the issued and outstanding
shares of Barringer Laboratories, Inc. stock owned by Barringer Technologies
Inc.
SIGNATURE
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE
REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE
UNDERSIGNED HEREUNTO DULY AUTHORIZED.
BARRINGER LABORATORIES, INC.
November 13, 1996 By /s/ Charles E. Ramsay
----------------------------
Charles E. Ramsay, Secretary
2
